Two Sigma Securities’s ASLAN Pharmaceuticals Limited American Depositary Shares ASLN Stock Holding History

Two Sigma Securities’s Portfolio ASLN Stock Details ASLN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,027	Closed	-$9.66K	–	3850
2024 Q2	$9.66K	Buy	+4,027	New	+$14.3K	﹤0.01%	2805

Other funds holding ASLN

RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return

Two Sigma Securities's ASLN Position: Q3 2024 in Review

Two Sigma Securities sold out of ASLAN Pharmaceuticals Limited American Depositary Shares (ASLN) in Q3 2024, closing a stake of 4,027 shares — an estimated $9.66K sold.

Two Sigma Securities first reported a position in ASLN in Q2 2024 and held it in 1 quarter. The position peaked at $9.66K in Q2 2024. 1 fund tracked by Wall St. Rank holds ASLN as of Q3 2024.

Two Sigma Securities reported no remaining ASLAN Pharmaceuticals Limited American Depositary Shares position as of Q3 2024 after selling out during the quarter.
Two Sigma Securities sold 4,027 ASLAN Pharmaceuticals Limited American Depositary Shares shares in Q3 2024, an estimated $9.66K.
Two Sigma Securities first reported a position in ASLAN Pharmaceuticals Limited American Depositary Shares in Q2 2024 and held it in 1 quarter.
Two Sigma Securities's ASLAN Pharmaceuticals Limited American Depositary Shares position peaked at $9.66K in Q2 2024.
1 fund tracked by Wall St. Rank held ASLAN Pharmaceuticals Limited American Depositary Shares as of Q3 2024.

Based on Two Sigma Securities's 13F filing for Q3 2024, filed 14 Nov 2024.